Exelixis Inc. Common Stock vs Nova Ltd — how do they compare? Exelixis Inc. Common Stock trades at $60.1 (market cap $14.62B), while Nova Ltd trades at $352.72 (market cap $11.28B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Nova Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Nova Ltd for 5 Days on average.
| EXEL | NVMI | |
|---|---|---|
Market Cap | $14.62B | $11.28B |
Volume | 2,684,957 | 394,997 |
Sector | Health | Technology |
52-Week High | $59.13 | $605.65 |
52-Week Low | $34.54 | $275.78 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $13.95B | $11.06B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →